At a glance
- Originator sigma-tau SpA
- Class Basic amino acids; Hypoxanthines; Small molecules
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Bacterial infections; Chemotherapy-induced damage
Most Recent Events
- 05 Dec 2000 No-Development-Reported for Bacterial infections in Italy (Unknown route)
- 05 Dec 2000 No-Development-Reported for Chemotherapy induced damage/Chemoprotection in Italy (Unknown route)
- 22 Feb 1995 Preclinical development for Chemotherapy induced damage/Chemoprotection in Italy (Unknown route)